Advertisement

Topics

Japan's Astellas acquires US stem cell firm for $102.5M

04:56 EST 15 Feb 2018 | SmartBrief

Astellas Pharma will pay $102.5 million upfront to acquire Seattle-based Universal Cells, the firm that developed the Univers -More

Original Article: Japan's Astellas acquires US stem cell firm for $102.5M

NEXT ARTICLE

More From BioPortfolio on "Japan's Astellas acquires US stem cell firm for $102.5M"

Advertisement
Quick Search
Advertisement
Advertisement